0.006 HKD
103.40 M HKD
6.59 M HKD
958.17 M
About INNOVATIVE PHARMACEUTICAL BIOTECH L
Sector
Industry
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG000C29519
Innovative Pharmaceutical Biotech Ltd. is an investment holding company, which engages in genetic testing, healthcare management, and distribution of bio-industrial products. The firm also focuses on developing insulin products that could be administered orally. It operates through the Trading of Beauty Products and Research and Development segments. The Trading of Beauty Products segment is involved in the trading of beauty products. The Research and Development segment includes research, development, and commercialization of the oral insulin product. The company was founded in 2000 and is headquartered in Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 399 is 0.189 HKD — it has decreased by −0.53% in the past 24 hours. Watch INNOVATIVE PHARMACEUTICAL BIOTECH L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange INNOVATIVE PHARMACEUTICAL BIOTECH L stocks are traded under the ticker 399.
399 stock has fallen by −1.56% compared to the previous week, the month change is a −3.08% fall, over the last year INNOVATIVE PHARMACEUTICAL BIOTECH L has showed a −5.50% decrease.
399 stock is 4.40% volatile and has beta coefficient of 0.15. Track INNOVATIVE PHARMACEUTICAL BIOTECH L stock price on the chart and check out the list of the most volatile stocks — is INNOVATIVE PHARMACEUTICAL BIOTECH L there?
Today INNOVATIVE PHARMACEUTICAL BIOTECH L has the market capitalization of 344.40 M, it has decreased by −1.04% over the last week.
Yes, you can track INNOVATIVE PHARMACEUTICAL BIOTECH L financials in yearly and quarterly reports right on TradingView.
399 net income for the last half-year is 101.74 M HKD, while the previous report showed −90.28 M HKD of net income which accounts for 212.69% change. Track more INNOVATIVE PHARMACEUTICAL BIOTECH L financial stats to get the full picture.
No, 399 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 20.00 employees. See our rating of the largest employees — is INNOVATIVE PHARMACEUTICAL BIOTECH L on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOVATIVE PHARMACEUTICAL BIOTECH L EBITDA is −14.19 M HKD, and current EBITDA margin is −189.49%. See more stats in INNOVATIVE PHARMACEUTICAL BIOTECH L financial statements.
Like other stocks, 399 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOVATIVE PHARMACEUTICAL BIOTECH L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOVATIVE PHARMACEUTICAL BIOTECH L technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOVATIVE PHARMACEUTICAL BIOTECH L stock shows the strong sell signal. See more of INNOVATIVE PHARMACEUTICAL BIOTECH L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.